Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Onsdag 28 Oktober | 17:16:01 Europe / Stockholm

Svenska | English

Investor Relations

Public Relations

Redeye

Bifogade filer

SenzaGen H2 2022 - In the right direction

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

SenzaGen H2 2022 - In the right direction

2023-02-17 09:28:00

Redeye provides an update in relation to SenzaGen’s H2 2022 report. We believe the year has been strong; sales came in a bit lower than our estimates; however, EBIT is better. We have chosen to only make minor changes in our estimates for the following years; however, following an updated Redeye rating, we change the WACC from 14.5% to 13.5%, resulting in a new fair value range with a base case of SEK21 (18).

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/